Compound ID | 1604
Novel Phloroglucinol Derivative 2
| Spectrum of activity: | Gram-positive |
| Details of activity: | Staphylococcus aureus |
| Institute where first reported: | University of Manitoba, Canada |
| Year first mentioned: | 2019 |
| Highest developmental phase: | Preclinical |
| External links: | |
| Citation: | https://www.nature.com/articles/s41429-019-0153-4 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.